Crossref
Research Progress of PCSK9 and Its Inhibitors in the Treatment of Hepatocellular Carcinoma
Pharmacy Information · 2026 · 15 (02) · 112-122
DOI: 10.12677/pi.2026.152014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacy Information, 2026. Verfasst von 亚峰 刘. Die Arbeit nennt 51 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
刘, 亚. (2026). Research Progress of PCSK9 and Its Inhibitors in the Treatment of Hepatocellular Carcinoma. Pharmacy Information, 15(02), 112-122. https://doi.org/10.12677/pi.2026.152014
Vancouver
刘 亚. Research Progress of PCSK9 and Its Inhibitors in the Treatment of Hepatocellular Carcinoma. Pharmacy Information. 2026;15(02):112-122. doi:10.12677/pi.2026.152014
BibTeX
@article{2026,
author = {刘, 亚峰},
title = {Research Progress of PCSK9 and Its Inhibitors in the Treatment of Hepatocellular Carcinoma},
journal = {Pharmacy Information},
year = {2026},
volume = {15},
number = {02},
pages = {112--122},
doi = {10.12677/pi.2026.152014}
}
EUVIMED